You are here:
NICE
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Metabolic conditions
Human growth hormone (somatropin) in adults with growth hormone deficiency
Technology appraisal guidance
Reference number:
TA64
Published:
27 August 2003
Guidance
Tools and resources
Information for the public
History
Download guidance (PDF)
Overview
1 Guidance
2 Clinical need and practice
3 The technology
4 Evidence and interpretation
5 Recommendations for further research
6 Implications for the NHS
7 Implementation and audit
8 Related guidance
9 Review of guidance
Appendix A. Appraisal Committee members
Appendix B. Sources of evidence considered by the Committee
Appendix C. Detail on criteria for audit of the use of human growth hormone (somatropin) in adults with growth hormone deficiency
Changes after publication
About this guidance
Changes after publication
March 2014:
minor maintenance
March 2012:
minor maintenance
Next page
About this guidance
Previous page
Appendix C. Detail on criteria for audit of the use of human growth hormone (somatropin) in adults with growth hormone deficiency